Anyone ever ask the question why nobody is talking about rantees besides CYDY? Hint: It's not bc Nader found the panacea
Anyone ever ask the question why there have only been a couple papers with COVID that measure rantees and there were no elevated levels?
Anyone ever ask the question why when leronlimab was initiated (on day 0) in the 5 patients with elevated interleukin-6 levels; these levels decreased markedly 3 days later (range, 37 to 2022 pg per milliliter) (see Table S2 in the Supplementary Appendix). However, only the 1 patient who had the lowest interleukin-6 level (at 83 pg per milliliter) remained in stable condition without intubation.
Then they switched their drug from an IL6 to a rantees? COOL PIVOT!
These are just run of the mill questions. Let's not answer with "BC Big Pharma is Scared!" pls